| dc.contributor.author |
Meydanli, MM |
|
| dc.contributor.author |
Kucukali, T |
|
| dc.contributor.author |
Usubutun, A |
|
| dc.contributor.author |
Ataoglu, O |
|
| dc.contributor.author |
Kafkasli, A |
|
| dc.date.accessioned |
2022-03-07T11:46:05Z |
|
| dc.date.available |
2022-03-07T11:46:05Z |
|
| dc.date.issued |
2002 |
|
| dc.identifier.uri |
http://hdl.handle.net/11616/54460 |
|
| dc.description.abstract |
Background. It is difficult to recognize epithelioid trophoblastic tumor (ETT) as a trophoblastic disease because of its rarity and growth pattern simulating a carcinoma. |
|
| dc.description.abstract |
Case report. A 36-year-old woman with stage IB1 squamous cell carcinoma of the uterine cervix and a high serum beta-human chorionic gonadotropin (beta-hCG) level underwent radical hysterectomy with pelvic and para-aortic lymphadenectomy. However, light microscopic findings and immunohistochemical studies with pan-cytokeratin, epithelial membrane antigen, inhibin-alpha, beta-hCG, and human placental lactogen revealed ETT of the endocervix. The patient is alive with no evidence of disease 12 months after surgery. |
|
| dc.description.abstract |
Conclusion. Before the patient is resorted to radical surgical interventions for assumed cervical carcinoma, ETT should be ruled out in women of reproductive age with endocervical tumors and elevated serum beta-hCG levels. (C) 2002 Elsevier Science (USA). |
|
| dc.source |
GYNECOLOGIC ONCOLOGY |
|
| dc.title |
Epithelioid trophoblastic tumor of the endocervix: A case report |
|